The effect of sex on the correlation between oscillometric and central aortic blood pressures (BP) is largely unknown. BP was simultaneously measured in the brachial artery using an oscillometric device and in the aorta using a fluid-filled catheter in 98 patients undergoing coronary angiography. Mean age (AEstandard deviation) was 58AE12 years, with 55% of the patients being male. Mean BP (MBP) measured by the oscillometric device and in the aorta were similar when the group was examined as a whole, but the oscillometric device overestimated MBP in men and underestimated MBP in women. Oscillometric pressures accurately estimated diastolic BP in women but overestimated diastolic BP in men and underestimated systolic BP in both sexes. The oscillometric device underestimated aortic pulse pressure in both sexes but less in men than in women. The accuracy of oscillometric MBP and diastolic BP varied as a function of aortic MBP, but sex-related differences in the accuracy of oscillometric pressures remained significant after adjusting for MBP, body mass index, height, age, race, heart rate, diabetes, smoking status, and BP-lowering therapies using a multivariate logistic regression model. Sex is an important determinant of the accuracy of oscillometric BP. J Clin Hypertens (Greenwich). 2011;13:112-119.
Introduction The optimal approach to managing terminal ileal (TI) Crohn’s disease remains to be defined. It is unclear at what stage surgery or biological therapy should be offered and current clinical and biochemical parameters offer poor prediction of disease course. Small bowel MRI scanning (SBMRI) has been correlated with endoscopic and histological disease severity in Crohn’s disease and may offer better global assessment of the extent and severity of disease. We aimed to determine which MRI features might predict the need for surgery or biological therapy. Methods 48 sequential patients with Crohn’s disease who underwent SBMRI in a 20 month period to Feb 2011 were identified from a radiological database. 8 patients were excluded due to predominant colonic disease. All remaining 40 patients had confirmed isolated TI disease. Standard management with escalation of therapy via immunomodulors, biological agents and surgery based on clinical follow up was applied. Patients were followed for a minimum of 2 years after the initial MRI. MRI scanning was performed using oral fluid load, IV buscopan, T1/2 axial, coronal and dynamic post contrast sequences. The images were reviewed by a radiologist blinded to outcome of cases and key abnormal features recorded (mesenteric abnormalities, wall thickness > 6 mm, disease extent > 15 cm or proximal dilatation > 25 mm). Patients were then divided into 2 groups, those requiring biological therapy or surgery (severe) and those managed with 5ASA or immunomodulators alone (non severe). Results The characteristic of the two groups is shown in the table. Means given unless stated. Abstract PTU-062 Table n Age CDAI at MRI CRP at MRI Years post diagnosis Previous surgery (%) Immunomodulator use (%) A Non severe 20 36 77 19 9.9 45 45 B Severe 20 42 120 30 9.8 45 75 6/20 patients in the non-severe group (A) had two or more adverse radiological features compared with 12/20 in the severe (B) group (p = 0.06). However, only 3/20 patients had lumen > 25 mm or extent > 15 cm in A compared with 15/20 in B (p < 0.001). Wall thickness and mesenteric involvement were not associated with a severe outcome. Disease extent and proximal luminal diameter were significantly associated with surgery (p = 0.02 and p = 0.0001). 85% of patients who eventually required surgery had either proximal lumen > 25 mm or disease extent > 15 cm. Conclusion Two or more adverse radiological MRI features are associated with with the need for surgery or biological therapy. Small bowel dilatation > 25 mm proximal to the disease segment and disease extent > 15 cm are particularly associated with the need for surgery. These MRI findings may be helpful in deciding appropriate longer term strategies for managing these patients. Disclosure of Interest None Declared
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.